Cargando…

COMP-angiopoietin-1 mitigates changes in lipid droplet size, macrophage infiltration of adipose tissue and renal inflammation in streptozotocin-induced diabetic mice

Adipose tissue is considered to be an endocrine organ, and adipocyte size correlates with insulin resistance and metabolic parameters in obesity. There is little data on the effects of angiopoietin-1 in adipose tissue and kidney in streptozotocin (STZ)-induced diabetes. In this study, we investigate...

Descripción completa

Detalles Bibliográficos
Autores principales: Jung, Yu Jin, Park, Woong, Nguyen-Thanh, Tung, Kang, Kyung Pyo, Jin, Heung Young, Kim, Suhn Hee, Suh, Wonhee, Kim, Won
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5706914/
https://www.ncbi.nlm.nih.gov/pubmed/29212268
http://dx.doi.org/10.18632/oncotarget.21998
_version_ 1783282314857414656
author Jung, Yu Jin
Park, Woong
Nguyen-Thanh, Tung
Kang, Kyung Pyo
Jin, Heung Young
Kim, Suhn Hee
Suh, Wonhee
Kim, Won
author_facet Jung, Yu Jin
Park, Woong
Nguyen-Thanh, Tung
Kang, Kyung Pyo
Jin, Heung Young
Kim, Suhn Hee
Suh, Wonhee
Kim, Won
author_sort Jung, Yu Jin
collection PubMed
description Adipose tissue is considered to be an endocrine organ, and adipocyte size correlates with insulin resistance and metabolic parameters in obesity. There is little data on the effects of angiopoietin-1 in adipose tissue and kidney in streptozotocin (STZ)-induced diabetes. In this study, we investigated the protective effect of COMP-angiopoietin-1 (COMP-Ang1), a potent variant of angiopoietin-1, on vascular endothelial cells in epididymal adipose tissue and its regulatory effect on other metabolic parameters, such as lipid droplet diameter, macrophage infiltration, and renal inflammation in STZ-treated mice. Our data showed that COMP-Ang1 increased the density of platelet endothelial cell adhesion molecule-1 (PECAM-1)-1-positive vascular endothelial cells in adipose tissue, which were significantly decreased by treatment with STZ. COMP-Ang1 ameliorated the STZ–induced decrease in lipid droplet diameter and increase in macrophage infiltration in adipose tissue. Serum free fatty acid and triglyceride levels were decreased after administration of COMP-Ang1. There was a beneficial effect on serum insulin levels after treatment with COMP-Ang1 in STZ-induced diabetic mice. Fasting blood glucose levels in COMP-Ang1-treated mice were significantly lower than those of LacZ-treated mice. Cotreatment with COMP-Ang1 and STZ also had similar effects on the above parameters. Administration of soluble Tie2, an inhibitor of angiopoietin-1, reversed the effects of COMP-Ang1. COMP-Ang1 was found to ameliorate the up-regulation of proinflammatory molecules and F4/80-positive macrophage infiltration in the kidneys of STZ-treated mice. COMP-Ang1 increased the phosphorylation of Akt in epididymal adipose tissue and kidneys of STZ-induced diabetic mice. These data indicate that COMP-Ang1 regulates lipogenic effects in adipose tissue and renal inflammation in STZ-induced diabetic mice.
format Online
Article
Text
id pubmed-5706914
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-57069142017-12-05 COMP-angiopoietin-1 mitigates changes in lipid droplet size, macrophage infiltration of adipose tissue and renal inflammation in streptozotocin-induced diabetic mice Jung, Yu Jin Park, Woong Nguyen-Thanh, Tung Kang, Kyung Pyo Jin, Heung Young Kim, Suhn Hee Suh, Wonhee Kim, Won Oncotarget Research Paper Adipose tissue is considered to be an endocrine organ, and adipocyte size correlates with insulin resistance and metabolic parameters in obesity. There is little data on the effects of angiopoietin-1 in adipose tissue and kidney in streptozotocin (STZ)-induced diabetes. In this study, we investigated the protective effect of COMP-angiopoietin-1 (COMP-Ang1), a potent variant of angiopoietin-1, on vascular endothelial cells in epididymal adipose tissue and its regulatory effect on other metabolic parameters, such as lipid droplet diameter, macrophage infiltration, and renal inflammation in STZ-treated mice. Our data showed that COMP-Ang1 increased the density of platelet endothelial cell adhesion molecule-1 (PECAM-1)-1-positive vascular endothelial cells in adipose tissue, which were significantly decreased by treatment with STZ. COMP-Ang1 ameliorated the STZ–induced decrease in lipid droplet diameter and increase in macrophage infiltration in adipose tissue. Serum free fatty acid and triglyceride levels were decreased after administration of COMP-Ang1. There was a beneficial effect on serum insulin levels after treatment with COMP-Ang1 in STZ-induced diabetic mice. Fasting blood glucose levels in COMP-Ang1-treated mice were significantly lower than those of LacZ-treated mice. Cotreatment with COMP-Ang1 and STZ also had similar effects on the above parameters. Administration of soluble Tie2, an inhibitor of angiopoietin-1, reversed the effects of COMP-Ang1. COMP-Ang1 was found to ameliorate the up-regulation of proinflammatory molecules and F4/80-positive macrophage infiltration in the kidneys of STZ-treated mice. COMP-Ang1 increased the phosphorylation of Akt in epididymal adipose tissue and kidneys of STZ-induced diabetic mice. These data indicate that COMP-Ang1 regulates lipogenic effects in adipose tissue and renal inflammation in STZ-induced diabetic mice. Impact Journals LLC 2017-10-23 /pmc/articles/PMC5706914/ /pubmed/29212268 http://dx.doi.org/10.18632/oncotarget.21998 Text en Copyright: © 2017 Jung et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Paper
Jung, Yu Jin
Park, Woong
Nguyen-Thanh, Tung
Kang, Kyung Pyo
Jin, Heung Young
Kim, Suhn Hee
Suh, Wonhee
Kim, Won
COMP-angiopoietin-1 mitigates changes in lipid droplet size, macrophage infiltration of adipose tissue and renal inflammation in streptozotocin-induced diabetic mice
title COMP-angiopoietin-1 mitigates changes in lipid droplet size, macrophage infiltration of adipose tissue and renal inflammation in streptozotocin-induced diabetic mice
title_full COMP-angiopoietin-1 mitigates changes in lipid droplet size, macrophage infiltration of adipose tissue and renal inflammation in streptozotocin-induced diabetic mice
title_fullStr COMP-angiopoietin-1 mitigates changes in lipid droplet size, macrophage infiltration of adipose tissue and renal inflammation in streptozotocin-induced diabetic mice
title_full_unstemmed COMP-angiopoietin-1 mitigates changes in lipid droplet size, macrophage infiltration of adipose tissue and renal inflammation in streptozotocin-induced diabetic mice
title_short COMP-angiopoietin-1 mitigates changes in lipid droplet size, macrophage infiltration of adipose tissue and renal inflammation in streptozotocin-induced diabetic mice
title_sort comp-angiopoietin-1 mitigates changes in lipid droplet size, macrophage infiltration of adipose tissue and renal inflammation in streptozotocin-induced diabetic mice
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5706914/
https://www.ncbi.nlm.nih.gov/pubmed/29212268
http://dx.doi.org/10.18632/oncotarget.21998
work_keys_str_mv AT jungyujin compangiopoietin1mitigateschangesinlipiddropletsizemacrophageinfiltrationofadiposetissueandrenalinflammationinstreptozotocininduceddiabeticmice
AT parkwoong compangiopoietin1mitigateschangesinlipiddropletsizemacrophageinfiltrationofadiposetissueandrenalinflammationinstreptozotocininduceddiabeticmice
AT nguyenthanhtung compangiopoietin1mitigateschangesinlipiddropletsizemacrophageinfiltrationofadiposetissueandrenalinflammationinstreptozotocininduceddiabeticmice
AT kangkyungpyo compangiopoietin1mitigateschangesinlipiddropletsizemacrophageinfiltrationofadiposetissueandrenalinflammationinstreptozotocininduceddiabeticmice
AT jinheungyoung compangiopoietin1mitigateschangesinlipiddropletsizemacrophageinfiltrationofadiposetissueandrenalinflammationinstreptozotocininduceddiabeticmice
AT kimsuhnhee compangiopoietin1mitigateschangesinlipiddropletsizemacrophageinfiltrationofadiposetissueandrenalinflammationinstreptozotocininduceddiabeticmice
AT suhwonhee compangiopoietin1mitigateschangesinlipiddropletsizemacrophageinfiltrationofadiposetissueandrenalinflammationinstreptozotocininduceddiabeticmice
AT kimwon compangiopoietin1mitigateschangesinlipiddropletsizemacrophageinfiltrationofadiposetissueandrenalinflammationinstreptozotocininduceddiabeticmice